Paolo Tarantino: When diagnosing ILD, the radiologist is your best friend
Paolo Tarantino shared on LinkedIn:
“When diagnosing Interstitial Lung Disease (ILD), the radiologist is your best friend.
It is a diagnosis of exclusion, warranting careful correlation of radiologic patterns with clinical features.
If adequately diagnosed, it can save lives, and allow patients to stay on highly effective anticancer drugs for longer.
Proud to share our latest educational article, just out in Insights Into Imaging, delving deep into the radiologist’s role in detecting cancer treatment related ILD.
In the article, we highlight the patophysiology, radiologic patterns and best practices for the diagnosis, monitoring and management of this important condition.
Open Access Link (download a copy!)”
The radiologist’s role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review
Autors: Julien Dinkel, Nikolaus Kneidinger and Paolo Tarantino
Source: Paolo Tarantino/LinkedIn
Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023